Calculus of urinary tract in diseases classified elsewhere (N22) is a clinical classification used for urinary stones (urolithiasis) that develop as a direct manifestation of a primary systemic, infectious, or metabolic disease documented in other chapters of the ICD-10-CM. Unlike primary urolithiasis, which may be idiopathic or related to localized urinary factors, stones in this category are secondary complications of an underlying pathology. A classic example is Schistosomiasis (B65.0), where eggs of the parasite Schistosoma haematobium deposited in the bladder or ureteral walls create a nidus for calcification. Other systemic drivers include primary hyperparathyroidism, which causes excessive calcium excretion (hypercalciuria), and distal renal tubular acidosis, which leads to alkaline urine and hypocitraturia, both of which significantly promote the precipitation of calcium-based stones. Per the ICD-10-CM instructional notes, clinicians must first code the underlying primary condition followed by N22 to indicate the presence of the resulting urinary calculi. Treatment involves addressing the acute clinical symptoms of the stone while simultaneously managing the root metabolic or infectious cause to prevent recurrence.
Mandatory Etiology Sequencing Requirement
Example: Patient with established idiopathic chronic tophaceous gout presents with acute renal colic. Diagnostic imaging confirms urolithiasis. Assessment: Idiopathic chronic tophaceous gout of unspecified site with other target organ involvement (M10.00) documented as the primary etiology, followed by calculus of urinary tract in diseases classified elsewhere (N22). Billing Focus: Manifestation code N22 must never be sequenced as the primary diagnosis. Risk Adjustment: Proper sequencing ensures the underlying systemic metabolic disorder is captured as the primary driver of complexity and HCC categorization.
Billing Focus: Sequence the underlying disease code first, followed by N22.
Specificity of the Underlying Condition
Example: Clinical Note: Patient with known Schistosomiasis haematobium infection presents for follow-up of bladder stones. Plan: Continue Praziquantel for Schistosomiasis (B65.0) and schedule cystolitholapaxy for secondary bladder calculus (N22). Billing Focus: Utilize specific codes for the infection or metabolic disease. Risk Adjustment: Specificity in the underlying etiology like Schistosomiasis improves the accuracy of the patient risk profile.
Billing Focus: Use the most specific code available for the underlying systemic disease.
Anatomical Site Correlation
Example: Urology Note: A 55-year-old male with Primary Hyperparathyroidism (E21.0) presents with right-sided nephrolithiasis. Imaging shows a 6mm stone in the renal pelvis. Assessment: Nephrolithiasis (N22) secondary to hyperparathyroidism. Billing Focus: While N22 is a general manifestation code, documentation should specify the exact location (e.g., kidney, ureter, bladder) in the narrative to support medical necessity for procedures. Risk Adjustment: Linking the site to the systemic metabolic cause justifies intensive specialist management.
Billing Focus: Document the precise anatomical location of the calculus within the urinary tract.
Documenting Metabolic and Genetic Drivers
Example: Evaluation: 19-year-old with Hereditary xanthinuria (E79.8). Recent ultrasound reveals multiple bilateral uric acid stones. Assessment: Urinary calculi (N22) as a manifestation of hereditary xanthinuria. Billing Focus: Coding the rare metabolic disorder as the primary condition. Risk Adjustment: Highlighting genetic and metabolic drivers indicates a lifelong chronic condition requiring frequent monitoring and high-intensity care.
Billing Focus: Explicitly link the calculus to a specific metabolic or genetic diagnosis.
Complication and Obstruction Detail
Example: ER Visit: Patient with gouty nephropathy (M10.30) presents with stone-induced hydronephrosis. CT confirms a 7mm obstructing ureteral calculus. Plan: Immediate stent placement for obstruction. Assessment: Gouty nephropathy with secondary calculus of urinary tract (N22) causing obstruction. Billing Focus: Documentation of obstruction is critical for justifying surgical intervention CPT codes. Risk Adjustment: Obstruction significantly increases the clinical risk level and mortality profile for the encounter.
Billing Focus: Document the presence or absence of urinary tract obstruction or hydronephrosis.
Used for routine follow-up of stable urinary calculi being managed medically for underlying metabolic issues.
Appropriate for patients with symptomatic stones, necessitating review of imaging and adjustment of metabolic therapy.
The standard surgical treatment for symptomatic or obstructing stones classified under N22.
Commonly used for non-obstructing renal stones secondary to metabolic disorders.
The gold standard for diagnosing the location and size of urinary stones.
Necessary when a stone secondary to an underlying disease causes acute obstruction.
Essential for diagnosing the underlying metabolic disease that causes the stone (N22).
Used in diagnosing primary hyperoxaluria or other rare metabolic causes of stones.
Commonly used for stones resulting from Schistosomiasis or chronic bladder conditions.
Necessary for a comprehensive first-time evaluation of a patient with metabolic stones and systemic disease.